• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

华盛顿州大肠杆菌O157:H7感染情况。全州疾病监测的第一年。

Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

作者信息

Ostroff S M, Kobayashi J M, Lewis J H

机构信息

Division of Field Services, Centers for Disease Control, Atlanta, Ga 30333.

出版信息

JAMA. 1989 Jul 21;262(3):355-9.

PMID:2661870
Abstract

In 1987, Washington became the first state to require that infection with Escherichia coli serotype O157:H7 be reported. In the first year of surveillance, 93 cases were reported, yielding an annual incidence of 2.1 cases per 100,000 population. The median age of case patients was 14 years (range, 11 months to 78 years), with the highest attack rate among children younger than 5 years (6.1 cases per 100,000 population per year). Bloody diarrhea was present in 95% of reported cases, 12% of patients developed either hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura, and one patient died. Suspected secondary cases were seen in 5% of households. Fifty-six (60%) cases occurred during June through September, as did 73% of the cases of hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura. Cases reported during the summer months were more likely than cases reported at other times of the year to be in children younger than 10 years. Medications, including antimicrobial medications, did not influence the duration of symptoms, nor did they appear to alter the risk of developing hemolytic-uremic syndrome or thrombotic thrombocytopenic purpura. This newly established surveillance system in Washington demonstrates that E coli O157:H7 is an important and common cause of bloody diarrhea in the United States.

摘要

1987年,华盛顿州成为首个要求报告感染大肠杆菌O157:H7病例的州。在监测的第一年,共报告了93例病例,年发病率为每10万人口2.1例。病例患者的中位年龄为14岁(范围为11个月至78岁),5岁以下儿童的发病率最高(每年每10万人口6.1例)。95%的报告病例出现血性腹泻,12%的患者发生了溶血尿毒综合征或血栓性血小板减少性紫癜,1例患者死亡。5%的家庭出现了疑似二代病例。56例(60%)病例发生在6月至9月,溶血尿毒综合征或血栓性血小板减少性紫癜病例的73%也发生在这一时期。夏季报告的病例比一年中其他时间报告的病例更有可能是10岁以下的儿童。包括抗菌药物在内的药物并未影响症状持续时间,也似乎未改变发生溶血尿毒综合征或血栓性血小板减少性紫癜的风险。华盛顿州新建立的监测系统表明,大肠杆菌O157:H7是美国血性腹泻的一个重要且常见的病因。

相似文献

1
Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.华盛顿州大肠杆菌O157:H7感染情况。全州疾病监测的第一年。
JAMA. 1989 Jul 21;262(3):355-9.
2
Illnesses associated with Escherichia coli O157:H7 infections. A broad clinical spectrum.与大肠杆菌O157:H7感染相关的疾病。临床谱广泛。
Ann Intern Med. 1988 Nov 1;109(9):705-12. doi: 10.7326/0003-4819-109-9-705.
3
A multistate outbreak of Escherichia coli O157:H7-associated bloody diarrhea and hemolytic uremic syndrome from hamburgers. The Washington experience.一起由汉堡引发的大肠杆菌O157:H7相关血性腹泻和溶血尿毒综合征的多州疫情。华盛顿的经历。
JAMA. 1994 Nov 2;272(17):1349-53.
4
A statewide outbreak of Escherichia coli O157:H7 infections in Washington State.华盛顿州大肠杆菌O157:H7感染的全州性暴发。
Am J Epidemiol. 1990 Aug;132(2):239-47. doi: 10.1093/oxfordjournals.aje.a115653.
5
A cluster of Escherichia coli O157:H7 infections with the hemolytic-uremic syndrome and death in California. A mandate for improved surveillance.加利福尼亚州发生的一群伴有溶血尿毒综合征及死亡病例的大肠杆菌O157:H7感染事件。加强监测的一项指令。
West J Med. 1996 Jul-Aug;165(1-2):15-9.
6
Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.大肠杆菌O157:H7感染期间的相对肾脏保护作用:与静脉补液扩容的关系
Pediatrics. 2005 Jun;115(6):e673-80. doi: 10.1542/peds.2004-2236.
7
Lake-associated outbreak of Escherichia coli O157:H7 in Clark County, Washington, August 1999.1999年8月,华盛顿州克拉克县与湖泊相关的大肠杆菌O157:H7疫情。
Arch Pediatr Adolesc Med. 2003 Oct;157(10):1016-21. doi: 10.1001/archpedi.157.10.1016.
8
Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.大肠杆菌O157:H7感染大规模暴发期间儿童溶血尿毒综合征的预测因素
Pediatrics. 1997 Jul;100(1):E12. doi: 10.1542/peds.100.1.e12.
9
Escherichia coli O157:H7, an emerging gastrointestinal pathogen. Results of a one-year, prospective, population-based study.大肠杆菌O157:H7,一种新出现的胃肠道病原体。一项为期一年的基于人群的前瞻性研究结果。
JAMA. 1988 Jun 24;259(24):3567-70.
10
Thrombotic thrombocytopenic purpura associated with Escherichia coli O157:H7--Washington.与大肠杆菌O157:H7相关的血栓性血小板减少性紫癜——华盛顿州
MMWR Morb Mortal Wkly Rep. 1986 Aug 29;35(34):549-51.

引用本文的文献

1
Impact of antibiotic treatment on hemolytic uremic syndrome risk in Escherichia coli O157 infections: a comprehensive systematic review and meta-analysis.抗生素治疗对大肠杆菌O157感染中溶血性尿毒症综合征风险的影响:一项全面的系统评价和荟萃分析。
Eur J Clin Microbiol Infect Dis. 2025 Apr 30. doi: 10.1007/s10096-025-05145-1.
2
Risk of Hemolytic Uremic Syndrome Related to Treatment of O157 Infection with Different Antimicrobial Classes.与使用不同抗菌类别治疗O157感染相关的溶血性尿毒症综合征风险
Microorganisms. 2021 Sep 21;9(9):1997. doi: 10.3390/microorganisms9091997.
3
First Isolation and Molecular Characterization of -Producing O157:H7 From Cattle in Xinjiang, China.
中国新疆牛源产志贺毒素O157:H7的首次分离与分子特征分析
Front Vet Sci. 2021 May 25;8:574801. doi: 10.3389/fvets.2021.574801. eCollection 2021.
4
Calculated initial parenteral treatment of bacterial infections: Bacterial gastrointestinal infections.细菌性感染的初始胃肠外治疗方案:细菌性胃肠道感染
GMS Infect Dis. 2020 Mar 26;8:Doc06. doi: 10.3205/id000050. eCollection 2020.
5
Shiga Toxin (Verotoxin)-producing 
 and Foodborne Disease: 
A Review.产志贺毒素(维罗毒素)与食源性疾病:综述
Food Saf (Tokyo). 2017 Jun 3;5(2):35-53. doi: 10.14252/foodsafetyfscj.2016029. eCollection 2017 Jun.
6
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.志贺毒素相关性溶血尿毒综合征:一篇叙述性综述。
Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067.
7
Importance of case age in the purported association between phylogenetics and hemolytic uremic syndrome in Escherichia coli O157:H7 infections.病例年龄在大肠杆菌 O157:H7 感染中假定的系统发生与溶血尿毒综合征之间的关联中的重要性。
Epidemiol Infect. 2018 Sep;146(12):1550-1555. doi: 10.1017/S0950268818001632. Epub 2018 Jun 19.
8
Shiga Toxin-Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis.产志贺毒素大肠杆菌感染、抗生素与溶血尿毒综合征发生风险:一项荟萃分析
Clin Infect Dis. 2016 May 15;62(10):1251-1258. doi: 10.1093/cid/ciw099. Epub 2016 Feb 24.
9
Serogroup-specific bacterial engineered glycoproteins as novel antigenic targets for diagnosis of shiga toxin-producing-escherichia coli-associated hemolytic-uremic syndrome.血清群特异性细菌工程糖蛋白作为诊断产志贺毒素大肠杆菌相关溶血尿毒综合征的新型抗原靶点。
J Clin Microbiol. 2015 Feb;53(2):528-38. doi: 10.1128/JCM.02262-14. Epub 2014 Dec 3.
10
Management of hemolytic-uremic syndrome in children.儿童溶血尿毒综合征的管理
Int J Nephrol Renovasc Dis. 2014 Jun 12;7:231-9. doi: 10.2147/IJNRD.S41837. eCollection 2014.